Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.
COPD is a syndrome akin to asthma but with important differences, including tobacco smoke-induced pathobiology and pulmonary emphysema. An exploration of how best to define ACOS is beyond the ...
“Addressing the unmet needs of patients with severe, uncontrolled asthma and COPD, particularly through innovative ...
Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...
The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback